Neogen Q2 FY2024 revenue $229.6M, net loss $(0.02)/sh; lowers full-year outlook

NEOGEN CORP

2024-Q2 EPS reported -$0.01 revenue$458,616,000

Revenue $229.6M, roughly flat YoY; Food Safety +1.9%, Animal Safety -5.0%.
Net loss $3.5M ($(0.02)/sh) vs prior $41.8M loss; Adjusted Net Income $24.9M ($0.11) vs $31.4M.
Adjusted EBITDA $55.1M (24.0% margin) vs $64.1M (27.8%) a year ago.
FY2024 guidance lowered: revenue $935M-$955M, Adj. EBITDA $230M-$240M; slower end-market recovery.
Animal Safety hurt by distributor destocking and Genomics shift; Food Safety core growth 0.7%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NEOGEN CORP reported second quarter ended November 30, 2023 results: revenue Revenue of $229.6 million., net income Net loss of $3.5 million; $(0.02) per diluted share.. Guidance reaffirmed.

Period: second quarter ended November 30, 2023
Revenue: Revenue of $229.6 million.
Net income: Net loss of $3.5 million; $(0.02) per diluted share.
Guidance: reaffirmed
Result: reported results

Exact text from the filing

regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces Second-Quarter 2024 Results • Revenue of $229.6 million. • Net loss of $3.5 million; $(0.02) per diluted share. • Adjusted Net Income of $24.9 million; $0.11 per diluted share. • Adjusted EBITDA of $55.1 million, at a margin of 24.0%.

View on SEC.gov

Browse all earnings releases →

NEOGEN CORP filing history →

Source: SEC EDGAR

accession 0000950170-24-003192

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.